STATE OF WISCONSIN INVESTMENT BOARD - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 129 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$768,014
+2148.1%
197,433
+1864.9%
0.00%
Q4 2022$34,163
-91.0%
10,048
-85.6%
0.00%
-100.0%
Q3 2022$381,000
+15.8%
69,730
-4.3%
0.00%0.0%
Q2 2022$329,000
-53.4%
72,844
-24.0%
0.00%0.0%
Q1 2022$706,000
+14.6%
95,8000.0%0.00%0.0%
Q4 2021$616,000
+11.0%
95,800
+0.4%
0.00%0.0%
Q3 2021$555,000
-43.7%
95,4000.0%0.00%
-50.0%
Q2 2021$985,000
-1.9%
95,4000.0%0.00%0.0%
Q1 2021$1,004,000
-35.1%
95,400
-4.6%
0.00%
-50.0%
Q4 2020$1,548,000
-21.3%
100,000
-25.8%
0.00%
-20.0%
Q3 2020$1,967,000
+5.1%
134,700
+36.3%
0.01%0.0%
Q2 2020$1,871,000
+6.0%
98,800
+7.5%
0.01%
-16.7%
Q1 2020$1,765,000
+6.3%
91,900
+6.1%
0.01%
+50.0%
Q4 2019$1,660,000
+99.3%
86,6000.0%0.00%
+100.0%
Q3 2019$833,000
+109.3%
86,600
+30.4%
0.00%
+100.0%
Q2 2019$398,000
+5.0%
66,400
+2.3%
0.00%0.0%
Q1 2019$379,000
-19.0%
64,900
+29.8%
0.00%
-50.0%
Q4 2018$468,000
-44.4%
50,000
+1.2%
0.00%0.0%
Q3 2018$841,000
+0.2%
49,4000.0%0.00%0.0%
Q2 2018$839,000
+140.4%
49,400
+90.0%
0.00%
+100.0%
Q1 2018$349,000
+39.6%
26,0000.0%0.00%0.0%
Q4 2017$250,000
-12.3%
26,0000.0%0.00%0.0%
Q3 2017$285,000
+21.3%
26,0000.0%0.00%0.0%
Q2 2017$235,00026,0000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders